Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Xiao, Fengxia ^a   Hiremath, Swapnil ^a   Knoll, Greg ^a   Zimpelmann, Joseph ^a   Srivaratharajah, Kajenny ^a   Jadhav, Deepak ^a   Fergusson, Dean ^a   Kennedy, Chris R J ^a   Burns, Kevin D ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; WESTERN BLOTTING;

ADULT; AGED; ANGIOTENSIN II; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SEX FACTORS;

EID: 84861309963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037649     Document Type: Article

References (28)

1. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: 1-9.
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243.
3. Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD, (2005) The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288: 353-362.
4. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, et al. (2007) Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292: 82-91.
5. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, et al. (2004) Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43: 1120-1125.
6. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, et al. (2006) Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 168: 1808-1820.
7. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, et al. (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171: 438-451.
8. Wysocki J, Ye M, Rodriguez E, González-Pacheco FR, Barrios C, et al. (2010) Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 55: 90-98.
9. Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, et al. (2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59: 529-538.
10. Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, et al. (2005) Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem 47: 39353-39362.
11. Iwata M, Silva Enciso JE, Greenberg BH, (2009) Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme. Am J Physiol Cell Physiol 297: 1318-1329.
12. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, et al. (2005) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280: 30113-30119.
13. Jia HP, Look DC, Tan P, Shi L, Hickey M, et al. (2009) Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 297: 84-96.
14. Mizuiri S, Aoki T, Hemmi H, Arita M, Sakai K, et al. (2011) Urinary ACE2 in patients with CKD. Nephrology (Carlton) 16: 567-572.
15. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annal Int Med 145: 247-254.
16. Dilauro M, Robertson S, Genest D, Burns KD, (2010) The effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiology 298: 1523-1532.
17. Hermann K, Rittweger R, Phillips MI, Ring J, (1992) Presence of angiotensin peptides in human urine. Clin Chem 38: 1768-1772.
18. Casarini DE, Plavinik FL, Zanella MT, Marson O, Krieger JE, et al. (2001) Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol 33: 75-85.
19. Su Z, Zimpelmann J, Burns KD, (2006) Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69: 2212-2218.
20. Koitka A, Cooper ME, Thomas MC, Tikellis C, (2008) Angiotensin converting enzyme 2 in the kidney. Clin Exp Pharmacol Physiol 35: 420-425.
21. Leehey DJ, Singh AK, Bast JP, Sethupathi P, Singh R, (2008) Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Transl Res 151: 208-216.
22. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM, (2008) Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 74: 1610-1616.
23. Ji H, Menini S, Zheng W, Pesce C, Wu X, et al. (2008) Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats. Exp Physiol 93: 648-657.
24. Wang G, Lai FM, Lai KB, Chow KM, Kwan CH, et al. (2008) Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy. Diabetologia 51: 1062-1067.
25. Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, et al. (2005) Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nature Med 8: 867-874.
26. Melenhorst WB, Visser L, Timmer A, van den Heuvel MC, Stegeman CA, et al. (2009) ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? Am J Physiol Renal Physiol 297: 781-790.
27. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, et al. (2009) Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 20: 363-379.
28. Mezzano S, Droguett A, Burgos ME, Ardiles LG, Flores CA, et al. (2003) Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int (Suppl 86:): 64-70.